CADL insiders were on both sides of the trade this year. Buys came to roughly $3 million (one buyer), sales to $3.6 million (three sellers).
The largest purchase came from Manning Paul B (Director), about $3 million.
On the institutional side, 138 funds reported holding CADL at the end of Q2 2026, and more funds bought than sold. Quarter by quarter: 2 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Tak Paul Peter | CEO | Sell | 220,866 | $11.50 | $2.5M | SEC |
| Sep 11, 2026 | Tak Paul Peter | CEO | Sell | 59,379 | $10.46 | $621K | SEC |
| Aug 19, 2026 | Tyagarajan Seshu | Executive Officer | Sell | 7,000 | $12.00 | $84K | SEC |
| Jul 1, 2026 | Barone Francesca | Executive Officer | Sell | 23,447 | $10.06 | $236K | SEC |
| Jul 1, 2026 | Tyagarajan Seshu | Executive Officer | Sell | 7,000 | $10.02 | $70K | SEC |
| Feb 26, 2026 | Manning Paul B | Director | Buy | 550,458 | $5.45 | $3.0M | SEC |
| Jul 30, 2025 | Nichols William Garrett | Executive Officer | Sell | 937 | $6.98 | $7K | SEC |
| Jul 2, 2025 | Nichols William Garrett | Executive Officer | Sell | 781 | $5.04 | $4K | SEC |
| Mar 20, 2025 | Nichols William Garrett | Executive Officer | Sell | 45,316 | $8.76 | $397K | SEC |
| Mar 20, 2025 | Barone Francesca | Executive Officer | Sell | 32,146 | $8.76 | $282K | SEC |
| Mar 20, 2025 | Tak Paul Peter | CEO | Sell | 400 | $9.00 | $4K | SEC |
| Mar 20, 2025 | Tak Paul Peter | CEO | Sell | 25,772 | $8.77 | $226K | SEC |
| Mar 20, 2025 | Tyagarajan Seshu | Executive Officer | Sell | 31,278 | $8.82 | $276K | SEC |
| Mar 19, 2025 | Tyagarajan Seshu | Executive Officer | Sell | 31,278 | $8.82 | $276K | SEC |
| Mar 19, 2025 | Schoch Charles | Officer | Sell | 5,000 | $8.83 | $44K | SEC |
In the last 12 months Candel Therapeutics, Inc. insiders made open-market purchases worth about $3 million and sales worth about $3.6 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CADL was filed on 2026-09-11.
138 investment managers reported holding CADL in SEC Form 13F filings for Q2 2026.
No congressional trades in CADL were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).